By Ashley Davidson, Director, Vault Study Startup, Veeva Systems, Inc.
Study start-up has significant impact on the overall speed of a trial, making it one of the most critical parts of the study process. Yet the resource-intensive study start-up phase of clinical trials is no faster today than a decade ago.
Encouragingly, adoption of study start-up applications is on the rise. Nearly one-quarter of respondents now use newer, purpose-built study start-up applications to speed cycle times. Streamlining study start-up enables trials to run more quickly, speeds site activation, and allows patients to be enrolled faster, ultimately speeding drug development. Continue reading to discover the top areas for improvement in today's study start-up processes.